Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: hasbeen101 who wrote (4834)	7/12/1998 8:00:00 PM
From: Brander	Read Replies (1) \| Respond to of 7041

The clinical studies reported flushing and nasal congestion as the most common side effects (if I remember correctly). Considering the nature of the drug, I would suspect that headache, nausea, diarrhea, sweating, visual disturbances could occur. More seriously, hypotension and cardiac arrhythmias could occur (based on side effects reported from intravenous and intramuscular phentolamine). Interestingly, no deaths due to acute toxicity have been reported with IV or IM phentolamine. Brad